EUVIMEDEUVIMED entdecken
Crossref

Safety and Outcomes of CD19 CAR-T Cell Therapy in Splenectomized Patients With B-Cell Lymphomas

Niveen Shibli, Sigrun Einarsdottir, Teng Fei, Roni Shouval, Miguel-Angel Perales, Marina Gomez-Llobell, Gunjan Shah, Shimrit Ringelstein-Harlev, Silvia Escribano-Serrat, Jabour Halloun, Uri Greenbaum, Jae H Park und 4 weitere

Transplantation and Cellular Therapy · 2026-11 · 32 (11) · 1419.e1-1419.e4

DOI: 10.1016/j.jtct.2026.06.044 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transplantation and Cellular Therapy, 2026-11. Verfasst von Niveen Shibli und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel; The Ruth and Bruce Rappaport Faculty of Medicine,…. Die Arbeit nennt 5 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Chimeric antigen receptor T (CAR-T) cell therapyRelapsed or refractory (R/R) B-cell malignanciesSplenectomized patients

Autor:innen und Institutionen

  • Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel; The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel.
  • Cellular Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York City, New York; Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Cente…
  • Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York City, New York.
  • Department of Hematology, Soroka University Medical Center and Faculty of Health and Science, Ben Gurion University of the Negev, Beer Sheva, Israel.
  • Cellular Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York City, New York; Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Department of Infectious Diseases, Rambam Health Care Campus, Haifa, Israel.

Zitieren

APA

Shibli, N., Einarsdottir, S., Fei, T., Shouval, R., Perales, M. A., Gomez-Llobell, M., Shah, G., Ringelstein-Harlev, S., Escribano-Serrat, S., Halloun, J., Greenbaum, U., Park, J. H., Stern, A., Zuckerman, T., Beyar-Katz, O., & Maroun, E. (2026). Safety and Outcomes of CD19 CAR-T Cell Therapy in Splenectomized Patients With B-Cell Lymphomas. Transplantation and Cellular Therapy, 32(11), 1419.e1-1419.e4. https://doi.org/10.1016/j.jtct.2026.06.044

Vancouver

Shibli N, Einarsdottir S, Fei T, Shouval R, Perales MA, Gomez-Llobell M, et al. Safety and Outcomes of CD19 CAR-T Cell Therapy in Splenectomized Patients With B-Cell Lymphomas. Transplantation and Cellular Therapy. 2026;32(11):1419.e1-1419.e4. doi:10.1016/j.jtct.2026.06.044

BibTeX
@article{Shibli2026,
  author = {Shibli, Niveen and Einarsdottir, Sigrun and Fei, Teng and Shouval, Roni and Perales, Miguel-Angel and Gomez-Llobell, Marina and Shah, Gunjan and Ringelstein-Harlev, Shimrit and Escribano-Serrat, Silvia and Halloun, Jabour and Greenbaum, Uri and Park, Jae H and Stern, Anat and Zuckerman, Tsila and Beyar-Katz, Ofrat and Maroun, Elias},
  title = {Safety and Outcomes of CD19 CAR-T Cell Therapy in Splenectomized Patients With B-Cell Lymphomas},
  journal = {Transplantation and Cellular Therapy},
  year = {2026},
  volume = {32},
  number = {11},
  pages = {1419.e1--1419.e4},
  doi = {10.1016/j.jtct.2026.06.044}
}
Kostenlos starten →